SpringWorks Therapeutics Inc (SWTX)
37.30
+0.75
(+2.05%)
USD |
NASDAQ |
Nov 15, 12:29
SpringWorks Therapeutics Cash from Operations (Quarterly): -41.79M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -41.79M |
| March 31, 2024 | -78.93M |
| December 31, 2023 | -62.70M |
| September 30, 2023 | -50.46M |
| June 30, 2023 | -47.81M |
| March 31, 2023 | -61.82M |
| December 31, 2022 | -54.20M |
| September 30, 2022 | -19.60M |
| June 30, 2022 | -39.07M |
| March 31, 2022 | -48.69M |
| December 31, 2021 | -46.32M |
| Date | Value |
|---|---|
| September 30, 2021 | -26.93M |
| June 30, 2021 | -33.53M |
| March 31, 2021 | -21.10M |
| December 31, 2020 | 15.07M |
| September 30, 2020 | -14.70M |
| June 30, 2020 | -16.16M |
| March 31, 2020 | -16.40M |
| December 31, 2019 | -16.06M |
| September 30, 2019 | -11.11M |
| June 30, 2019 | -13.09M |
| March 31, 2019 | -7.177M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-78.93M
Minimum
Mar 2024
15.07M
Maximum
Dec 2020
-35.85M
Average
-39.07M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Ocugen Inc | -9.911M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -6.472M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.289M |
| Cash from Financing (Quarterly) | 3.371M |
| Free Cash Flow | -248.01M |
| Free Cash Flow Per Share (Quarterly) | -0.7287 |
| Free Cash Flow to Equity (Quarterly) | -54.02M |
| Free Cash Flow Yield | -9.65% |